- Home
- GTBP vs PPBT Comparison
GTBP vs PPBT Comparison
Compare GTBP & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- PPBT
- Stock Information
- Founded
- GTBP 1965
- PPBT 2010
- Country
- GTBP United States
- PPBT Israel
- Employees
- GTBP N/A
- PPBT N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- GTBP Health Care
- PPBT Health Care
- Exchange
- GTBP Nasdaq
- PPBT Nasdaq
- Market Cap
- GTBP 6.6M
- PPBT 6.7M
- IPO Year
- GTBP N/A
- PPBT N/A
- Fundamental
- Price
- GTBP $2.13
- PPBT $3.78
- Analyst Decision
- GTBP Strong Buy
- PPBT Strong Buy
- Analyst Count
- GTBP 1
- PPBT 2
- Target Price
- GTBP $11.00
- PPBT $126.50
- AVG Volume (30 Days)
- GTBP 23.9K
- PPBT 2.7M
- Earning Date
- GTBP 11-14-2024
- PPBT 11-15-2024
- Dividend Yield
- GTBP N/A
- PPBT N/A
- EPS Growth
- GTBP N/A
- PPBT N/A
- EPS
- GTBP N/A
- PPBT N/A
- Revenue
- GTBP N/A
- PPBT N/A
- Revenue This Year
- GTBP N/A
- PPBT N/A
- Revenue Next Year
- GTBP N/A
- PPBT N/A
- P/E Ratio
- GTBP N/A
- PPBT N/A
- Revenue Growth
- GTBP N/A
- PPBT N/A
- 52 Week Low
- GTBP $1.92
- PPBT $2.00
- 52 Week High
- GTBP $10.66
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- GTBP 40.32
- PPBT 48.29
- Support Level
- GTBP $2.41
- PPBT $3.56
- Resistance Level
- GTBP $3.40
- PPBT $4.22
- Average True Range (ATR)
- GTBP 0.30
- PPBT 1.40
- MACD
- GTBP -0.04
- PPBT -0.07
- Stochastic Oscillator
- GTBP 6.09
- PPBT 4.11
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.